ON/GO Rapid COVID-19 Antigen Self-Test Kit, 1 Case (288 Tests) — 15-Min Results, App-Guided

ON/GO One is an FDA EUA-authorized rapid antigen self-test kit that delivers results in about 15 minutes and connects to the ON/GO app for optional test-to-treat support.

Designed for businesses, events, and organizations needing dependable bulk testing, this 1-case pack contains 288 individual ON/GO One rapid COVID-19 antigen tests. Each kit uses a shallow nasal swab for user comfort, produces a visual result in approximately 15 minutes, and integrates with the ON/GO mobile app to guide testing and, when eligible, help users access treatment options through the platform.

How quickly will I get a result and how simple is the test to use?

The ON/GO One test returns a readable result in about 15 minutes using a straightforward shallow anterior nasal swab. The test procedure is intentionally simple: collect the sample, apply it to the test strip, wait the specified time, and read the result. For added guidance, the ON/GO app walks users step-by-step and can help interpret results.

• Average result time: ~15 minutes
• Sample type: shallow nasal swab for greater comfort
• App support: step-by-step testing walkthrough and result capture
• Intended users: symptomatic and asymptomatic individuals

Is ON/GO One approved and accurate enough for organizational use?

ON/GO One is authorized under an FDA Emergency Use Authorization (EUA) for at-home antigen testing and has documented performance across known variants. The manufacturer reports high sensitivity metrics when used according to instructions; organizations commonly rely on these tests for screening at gatherings, workplaces, and events.

• Regulatory status: FDA EUA authorized
• Performance: manufacturer-reported high accuracy across major variants
• Use cases: screening, return-to-work checks, event entry testing
• Comfort design: shallow swab suitable for repeated testing

What additional services does the ON/GO app provide after a positive result?

The ON/GO app bridges testing and care by guiding users through eligibility checks and, where appropriate, facilitating prescriptions or telehealth referrals. If the app determines a user is eligible, it can support same-day fulfillment of authorized therapeutics through partnered services, reducing friction between a positive test and accessing care.

• App features: guided testing, eligibility screening, telehealth connection
• Treatment access: potential same-day prescription fulfillment if eligible
• Delivery option: partnered delivery for authorized therapeutics
• Privacy: user-directed data sharing through the app

How should organizations manage inventory, reimbursement, and shelf life?

Bulk purchasers can plan distribution across employees, attendees, or facilities; ON/GO provides updated shelf-life information and links for tracking expiration dates. Some private insurance plans previously offered reimbursements for at-home tests; buyers should confirm current reimbursement policies and program deadlines with insurers and the ON/GO resources.

• Inventory size: this case contains 288 individual tests
• Shelf-life: manufacturer and FDA have published extensions—verify expiration before use
• Insurance: check private plan coverage and reimbursement requirements directly
• Distribution tips: store per instructions and rotate stock by expiration date

Who is this for? ON/GO One in this 288-test case is aimed at businesses, event organizers, schools, clinics, and community groups that need reliable, rapid antigen testing at scale. It suits any setting that requires frequent screening, quick decision-making, and optional app-based support to help connect positive testers with next-step care.